BioSpace News Archive

Business

Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2022 Financial Results and Discuss Recent Corporate Highlights

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, May 5, 2022 to report financial results for the quarter ended March 31, 2022 and discuss recent corporate highlights.

April 27, 2022
·
1 min read
Biotech Beach

Sonendo, Inc. To Showcase Newly Launched CleanFlow™ Technology at 2022 AAE Annual Meeting

Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, is participating in the American Association of Endodontists’ (AAE) Annual Meeting taking place from April 27-30, 2022 in Phoenix, AZ.

April 27, 2022
·
3 min read
Business

Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

Charles River Laboratories International, Inc. (NYSE: CRL) and Valo Health, Inc (“Valo”) have launched Logica TM , an artificial intelligence (AI) powered drug solution that directly translates clients’ biological insights into optimized preclinical assets.

April 27, 2022
·
4 min read
Paragon 28 Launches Paratrooper™ Plantar Plate System for Hammertoe and Soft Tissue Repair

Paragon 28, Inc. announced today an expansion of its hammertoe and soft-tissue portfolio with the launch of its Paratrooper™ Plantar Plate Repair System.

April 27, 2022
·
2 min read
Horizon Therapeutics plc Among Top Companies for Overall Corporate Reputation in 2021 Global PatientView Survey of Patient Groups Worldwide

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked fifth in overall corporate reputation among patient groups that have worked directly with the company and seventh among patient groups who were familiar with the company.

April 27, 2022
·
3 min read
Business

Highland Therapeutics Announces Appointment of Stephanie C. Read as President/CEO, Changes to Board of Directors

Highland Therapeutics Inc. today announced the appointment of Stephanie C. Read as President/Chief Executive Officer, the appointment of Scott Myers as Chair of the Board and the additions of Kevin Bain and Ildiko Mehes as independent members of the Board of Directors.

April 27, 2022
·
12 min read
BioForest

Visus Therapeutics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meeting

Visus Therapeutics Inc. today announced that it will present new scientific data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting , to be held May 1-4, 2022 in Denver, Colorado.

April 27, 2022
·
3 min read
Business

Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022

Arcturus Therapeutics Holdings Inc. today announced that it will release its financial results for the quarter ended March 31, 2022 after the market close on Monday, May 9 and will also host a conference call and webcast at 4:30 pm Eastern Daylight Time on May 9, 2022.

April 27, 2022
·
2 min read
BioMidwest

Truvian Sciences President and CEO Jeff Hawkins to Speak Among Leaders of Nation’s Most Innovative Labs at The Dark Intelligence Group’s Executive War College Conference

Truvian Sciences President and CEO Jeff Hawkins joins leaders of the nation’s most innovative labs to share new technologies and approaches to improve patient outcomes.

April 27, 2022
·
1 min read
Genetown

Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy DayLive event in New York City and webcast to start at 8:30 a.m. ET

Praxis Precision Medicines, Inc. will host its 2022 Epilepsy Day live in New York City and via webcast from 8:30 to 11:30 a.m. ET.

April 27, 2022
·
4 min read